Lion Biotechnologies Announces Allowance of IND Application to Begin Clinical Trials in Cervical, Head and Neck Cancers Read more about Lion Biotechnologies Announces Allowance of IND Application to Begin Clinical Trials in Cervical, Head and Neck Cancers
Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer Read more about Lion Biotechnologies Names Steven A. Fischkoff Chief Medical Officer
Lion Biotechnologies to Participate in Upcoming Conferences Read more about Lion Biotechnologies to Participate in Upcoming Conferences
Lion Biotechnologies Announces 2015 Fourth-Quarter and Year-End Financial Results Read more about Lion Biotechnologies Announces 2015 Fourth-Quarter and Year-End Financial Results
Lion Biotechnologies Names Michael T. Lotze Chief Scientific Officer Read more about Lion Biotechnologies Names Michael T. Lotze Chief Scientific Officer
Lion Biotechnologies Manufacturing Capabilities and Research Programs Unaffected by Review of National Cancer Institute's Manufacturing Facilities Read more about Lion Biotechnologies Manufacturing Capabilities and Research Programs Unaffected by Review of National Cancer Institute's Manufacturing Facilities
Lion Biotechnologies Announces First Quarter 2016 Financial Results Read more about Lion Biotechnologies Announces First Quarter 2016 Financial Results
Lion Biotechnologies Appoints Maria Fardis, Ph.D., as CEO Read more about Lion Biotechnologies Appoints Maria Fardis, Ph.D., as CEO
Lion Biotechnologies Raises Approximately $100 Million in Private Placement Read more about Lion Biotechnologies Raises Approximately $100 Million in Private Placement
Lion Biotechnologies to Present at the Jefferies 2016 Healthcare Conference Read more about Lion Biotechnologies to Present at the Jefferies 2016 Healthcare Conference